Shareholders approve 2026 Equity Plan, elect 11 directors at annual meeting

Chemours Co

2026 Equity Plan approved with ~96.7% of votes cast; authorizes 6,375,275 shares for issuance.
All 11 director nominees elected with 95.8% to 99.3% of votes cast for each.
Say-on-pay advisory vote approved with 97.5% of votes cast in favor.
Ratification of PricewaterhouseCoopers LLP as independent auditor approved with 99.4% of votes cast.
Plan replaces 2017 Equity and Incentive Plan; prior awards reduce share reserve on a one-for-one basis.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.